Jyothy Labs: Should You Buy, Hold, or Sell Right Now?

Jyothy Labs share price Rs 202.09 (NSE), near its 52-week low. 52-week range Rs 188.10 to Rs 347. Q1 FY27 revenue up 3% YoY, profit fell about 51% on margin squeeze.

Jyothy Labs share price is trading close to its 52-week low of Rs 188.10, with Jyothy Labs share price near Rs 202 on the NSE, well off its 52-week high of Rs 347. With volume growth overshadowed by unprecedented margin compression in Q1 FY27, investors are asking whether this home and personal care company is a stock to buy near its lows, a hold, or a sell given the severity of the cost pressure.

This Jyothy Labs stock analysis walks through the Q1 FY27 numbers, the specific input cost drivers behind the margin squeeze, valuation against the FMCG sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings.

Click Here – Get Free Investment Predictions

About Jyothy Labs

Keep this backdrop in mind when reading the rest of this Jyothy Labs share price review. Before deciding on Jyothy Labs share price, it helps to understand the underlying business. Jyothy Labs Ltd. is an Indian FMCG company with a portfolio spanning fabric care, home care and personal care segments, home to well-known brands including Ujala fabric whitener, Exo dishwash, Henko detergent, Margo soap and Maxo mosquito repellents. Fabric Care and Home Care together account for the large majority of the company’s revenue.

The company’s cost base is unusually exposed to crude oil-derived raw materials, with management estimating approximately 90 percent of costs tied to crude-linked inputs, making Jyothy Labs particularly sensitive to commodity price swings relative to many other FMCG peers with more diversified input structures.

Jyothy Labs Share Price Today: Key Levels

The table below summarises where Jyothy Labs share price stands right now against its recent trading range and market value.

Jyothy Labs share price is trading near its 52-week low, reflecting the market’s focus on the severity of the recent margin compression rather than the underlying volume growth the company continues to post.

Check the Univest Screener for Live Stock Data

Jyothy Labs Financial Performance

Track this line item closely if you are following Jyothy Labs share price closely. The Jyothy Labs share price trend is closely tied to how these numbers evolve each quarter. Jyothy Labs reported Q1 FY27 (June 2026 quarter) revenue of Rs 773 crore, up 3 percent year on year, though excluding divested brands Pril and Fa, value growth was a healthier 8.1 percent with 5.3 percent volume growth. Net profit fell sharply to Rs 47.64 crore from Rs 96.79 crore a year earlier, as gross margin contracted by nearly 950 basis points and EBITDA margin fell to 8.4 percent from 16.5 percent.

Management attributed the margin deterioration primarily to crude-linked input cost inflation estimated at 30 to 35 percent during the quarter, with approximately 90 percent of the company’s cost base tied to crude oil-derived materials, leaving limited ability to pass through costs given competitive pricing pressure. Management has guided for progressive margin recovery starting from October if commodity prices stabilise, with full-year FY27 EBITDA margins expected to remain under pressure in the first half before improving in the second half.

Valuation Check: Is Jyothy Labs Share Price Expensive?

It is one of the clearest signals available on Jyothy Labs share price today. Any view on Jyothy Labs share price should start from these valuation multiples. Jyothy Labs share price currently reflects a price to earnings ratio of about 26.1 times trailing earnings, a discount to the FMCG sector average of roughly 37.8 times. The price to book ratio stands near 4.7 times, with return on equity at 20.97 percent, still healthy on a trailing basis even though it will likely moderate as the weaker recent quarter feeds into calculations.

Debt to equity of 0.03 is minimal. Historically, FMCG companies facing temporary input cost shocks have seen valuations compress until margin recovery is confirmed, so the current discount reflects the market pricing in near-term uncertainty about the pace and extent of the guided margin recovery.

Technical Signals: What the Chart Shows

Price action here often foreshadows the next move in Jyothy Labs share price. Jyothy Labs share price is currently positioned about 42 percent below its 52-week high of Rs 347 and roughly 7 percent above its 52-week low of Rs 188.10, placing it near the bottom of its annual trading range following the severe margin compression reported in Q1 FY27. A stock trading this close to its low after such a sharp margin miss typically reflects the market discounting near-term earnings uncertainty while awaiting confirmation of the guided recovery.

Trading volumes remain low, so investors should track Jyothy Labs share price closely around commodity price trends and the company’s guided October margin recovery timeline, rather than reacting to any single day’s move at these technical levels.

Download the Univest iOS App or Univest Android App to track Jyothy Labs’ live price and technical levels.

Shareholding Pattern

Shifts here can influence Jyothy Labs share price more than headline news on some sessions. Jyothy Labs is promoted by founder M. P. Ramachandran and the Jyothy family, who have led the company since it was built around the flagship Ujala brand in 1983. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company’s latest exchange filing.

Why Investors Are Watching Jyothy Labs

• Underlying volume growth remains healthy: Excluding divested brands, value growth of 8.1 percent and volume growth of 5.3 percent show the core business continues to gain traction with consumers.
• Clear management recovery timeline: Management has guided for progressive margin recovery from October 2026 if commodity prices stabilise, giving investors a specific milestone to track.
• Valuation discount to sector: A 26.1x PE against a 37.8x FMCG sector average offers a valuation cushion if the guided margin recovery materialises.
• Established, trusted brand portfolio: Long-standing brands like Ujala, Exo, Henko and Maxo give Jyothy Labs durable consumer recognition across its core categories.

Risks and Factors to Watch

• Severe near-term margin compression: EBITDA margin fell to 8.4 percent from 16.5 percent in a single quarter, a very sharp deterioration that highlights the company’s unusual sensitivity to crude-linked input costs.
• High cost base exposure to crude oil: With approximately 90 percent of costs tied to crude-linked inputs, Jyothy Labs is unusually exposed to commodity volatility relative to many FMCG peers.
• Limited pricing power in a competitive market: Management noted limited ability to pass through cost increases given competitive pricing pressure, which constrains near-term margin recovery options.
• Uncertain recovery timing: The guided margin recovery from October depends on commodity prices stabilising, a factor outside the company’s direct control.

Jyothy Labs Share Price Target: What the Data Suggests

Until then, Jyothy Labs share price remains best tracked through live, verified data rather than a single fixed number. Jyothy Labs does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, particularly given the sharp recent margin volatility. What the data shows is a company with healthy underlying volume growth facing a severe, largely input-cost-driven margin squeeze that management expects to ease from the second half of FY27.

Historically, FMCG companies facing temporary commodity cost shocks have recovered once input prices stabilise. Investors who want live, updated research can check the Univest Screener, and should consult a SEBI-registered investment adviser given the near-term margin uncertainty in this stock.

Jyothy Labs: Should You Buy, Hold, or Sell Right Now?

This is the core question behind Jyothy Labs share price right now. The Jyothy Labs buy or sell decision depends on how much confidence you place in management’s guided margin recovery timeline.

The case for buying: Investors who see the healthy underlying volume growth and believe management’s guidance for margin recovery from October may find the stock’s proximity to its 52-week low an attractive entry point.

The case for holding: Existing shareholders who already track Jyothy Labs’ brand strength and historical resilience may prefer to stay invested through this input cost cycle.

The case for trimming or waiting: Investors wanting to see actual evidence of margin recovery before committing fresh capital, given how sharp and sudden the recent decline was, may prefer to wait for confirmation closer to or after October.

Historically, FMCG companies have recovered from commodity-driven margin shocks, but the timing can be uncertain, so weigh this against your own investment horizon and consult a SEBI-registered investment adviser if unsure.

Conclusion

Jyothy Labs share price reflects an FMCG home and personal care company facing a severe, largely input-cost-driven margin squeeze in Q1 FY27, even as underlying volume growth remains healthy, trading near its 52-week low at a discount to the FMCG sector. Whether that makes the stock a buy, a hold or a sell right now depends on your confidence in management’s guided margin recovery from October. This article is for informational purposes and not a personalised investment recommendation.

Q1. Is Jyothy Labs a good stock to buy right now?

Ans. Jyothy Labs posted healthy underlying volume growth of 5.3 percent in Q1 FY27, but profit fell sharply due to severe input cost inflation, with EBITDA margin falling to 8.4 percent from 16.5 percent. The stock trades near its 52-week low at a discount to the FMCG sector, which may appeal to investors who believe management’s guided margin recovery from October.

Q2. Why did Jyothy Labs profit fall so much in Q1 FY27?

Ans. Jyothy Labs’ Q1 FY27 net profit fell to Rs 47.64 crore from Rs 96.79 crore a year earlier, driven by gross margin compression of nearly 950 basis points as crude-linked input costs surged an estimated 30 to 35 percent, with the company’s cost base unusually exposed given about 90 percent of costs are tied to crude oil-derived materials.

Q3. What is the Jyothy Labs share price today?

Ans. Jyothy Labs share price is trading around Rs 202 on the NSE, near its 52-week low of Rs 188.10. The stock’s 52-week high is Rs 347.

Q4. What is the Jyothy Labs share price target?

Ans. Jyothy Labs does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. Investors can check live research on the Univest Screener and consult a SEBI-registered adviser.

Q5. When does Jyothy Labs expect margins to recover?

Ans. Jyothy Labs management has guided for progressive margin recovery starting from October 2026, contingent on crude-linked commodity prices stabilising, with full-year FY27 margins expected to remain under pressure in the first half before improving in the second half.

Q6. What brands does Jyothy Labs own?

Ans. Jyothy Labs owns well-known Indian FMCG brands including Ujala fabric whitener, Exo dishwash, Henko detergent, Margo soap and Maxo mosquito repellents, spanning fabric care, home care and personal care segments.